NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems, provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. As per the
The trial, also referred to as Response, is a global, randomised study of efficacy and safety in polycythemia vera patients who are resistant or intolerant of hydroxyurea. Response
The grants are related to four of Palatin’s projects – melanocortin agonists for sexual dysfunction; melanocortin agonists for obesity and related metabolic syndrome; natriuretic peptide mimetic PL-3994 for
The increase in revenue was due to $44.2m of profit share earned from commercial sales of Enoxaparin sodium injection and the $5m regulatory milestone earned upon FDA marketing
Acorda has posted a net income of $12.44m for the third quarter 2010, or $0.31 per diluted share, compared to net loss of $19.43m, or $0.51 loss per
Coombs is appointed to the Audit and Corporate Governance Committees while Fischer is appointed to the Audit and Compensation Committees. Coombs, retired since 2008 from Tetra Technologies, served
In the CRL, the FDA has asked additional information in relation to the Linjeta (human insulin [rDNA origin]) injection 100IU/ml NDA for the treatment of type 1 and
Migalastat HCl is an investigational treatment for fabry disease and has the potential to be the first in a new class of oral, small molecule medicines called pharmacological
This accelerated approval of Afinitor is based on an open-label, single-arm, 28-patient study conducted by Cincinnati Children’s Hospital Medical Center. The effectiveness of Afinitor is based on an
According to Roche, the EC approval is based on the results from the phase III Prima study which demonstrated that continuing MabThera for two years (maintenance treatment) in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.